Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone versus topical tranexamic acid for prevention of rebleeding in traumatic hyphema
IRCT20201110049345N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of prednisolone and tranexamic acid in hyphema (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Rebleeding in patients with traumatic hyphema. Started Aug 2018; status: completed.
02
Drugs
prednisolonetranexamic acid
03
Conditions
hyphema
Beyond the preview
Go deeper on IRCT20201110049345N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201110049345N1.